Table 1.

Characteristics of patients before and after NA treatment

NA treatment duration (years), n = 167	5.8±2.8
ETV, n = 72	4.4±1.9
LMV only, n = 57	6.5±3.1
LMV plus ADV, n = 38	7.3±2.8
	Before NA treatment	After NA treatment
Age (years)	49.2 ± 11.1	56.7 ± 25.4
Gender (male/female)	112/55	—
Chronic hepatitis/liver cirrhosis	126/41	—
HBV DNA (log copies/ml)	6.8 ± 1.3	1.6 ± 1.5
HBV genotype (A/B/C/ND)	3/4/144/16	—
HBeAg positive	81 (50.9%)	42 (25.6%)
HBsAg (< 2000/ ≥ 2000 C.O.I.)	8/159	28/139

Values are mean ± standard deviation (SD). ND = no data; C.O.I. = cut off index.